MS

Martin SCHÄFER

DK Deutsches Krebsforschungszentrum: 4 patents #24 of 345Top 7%
RH Ruprecht - Karls - Universität Heidelberg: 4 patents #15 of 222Top 7%
NA Novartis Ag: 2 patents #1,923 of 5,128Top 40%
📍 Neckarsteinach, DE: #8 of 32 inventorsTop 25%
Overall (All Time): #793,890 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11951190 Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer Matthias Eder, Klaus Kopka, Ulrike BAUDER-WÜST, Michael Eisenhut, Walter Mier +1 more 2024-04-09
11931430 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer Matthias Eder, Klaus Kopka, Ulrike BAUDER-WÜST, Michael Eisenhut, Walter Mier +1 more 2024-03-19
11045564 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer Matthias Eder, Klaus Kopka, Ulrike BAUDER-WÜST, Michael Eisenhut, Walter Mier +1 more 2021-06-29
10471160 Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Matthias Eder, Klaus Kopka, Ulrike BAUDER-WÜST, Uwe Haberkorn, Michael Eisenhut +4 more 2019-11-12
10398791 Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Matthias Eder, Klaus Kopka, Ulrike BAUDER-WÜST, Uwe Haberkorn, Michael Eisenhut +2 more 2019-09-03
10016519 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Klaus Kopka, Martina Benesova, Jens Cardinale, Matthias Eder, Ulrike BAUDER-WÜST +2 more 2018-07-10